Abnormalities of ear ossicles

H8_OSSICABN

Otitis media: Inflammation of the anatomical structures of the middle ear, which is most often caused by an infectious process. Symptoms include erythema and edema of the tympanic membrane, pain, and possibly fever.

Suggest a new description

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H74.3
  • Cause of death: ICD-10 H74.3

2 out of 7 registries used, show all original rules.

80

4. Check minimum number of events

None

80

5. Include endpoints

None

80

6. Filter based on genotype QC (FinnGen only)

68

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H74
Name in latin
Aliae abnormitates acquisitae ossiculorum auditoriorum

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 581 315 265
Only index persons 568 307 261
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 47.99 48.47 47.44
Only index persons 47.28 47.17 47.40

-FinnGen-

Key figures

All Female Male
Number of individuals 68 44 24
Unadjusted period prevalence (%) 0.01 0.02 0.01
Median age at first event (years) 51.04 49.46 53.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
71
Matched controls
710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
+∞
102.0
71
*
UDC00
NOMESCO Finland
Ear microscopy
17.8
29.9
30
28
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
125.8
24.5
25
*
DFF00
NOMESCO Finland
Pure tone audiometry
12.6
23.1
29
37
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
+∞
22.0
20
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
9.7
19.1
30
50
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
54.5
17.4
20
5
H80.9
ICD-10 Finland
Otosclerosis, unspecified
109.7
16.4
17
*
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
73.1
15.6
17
*
DDA00
NOMESCO Finland
Stapedotomy
101.4
15.3
16
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
+∞
14.0
13
*
DCD10
NOMESCO Finland
Tympanoplasty
+∞
14.0
13
*
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
12.9
12
*
DDD10
NOMESCO Finland
Interposition between malleus and stapes
+∞
11.8
11
*
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
11.8
11
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
71.0
11.0
12
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
+∞
10.7
10
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
12.3
10.0
18
19
DFF15
NOMESCO Finland
Speech audiometry
15.5
10.0
16
13
DAX08
NOMESCO Finland
Fitting of hearing aid
11.1
9.5
18
21
ZXC10
NOMESCO Finland
Use of laser
17.3
8.6
13
9
DDW99
NOMESCO Finland
Other operation on ossicles of ear
+∞
8.5
8
*
DCD00
NOMESCO Finland
Myringoplasty
+∞
8.5
8
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
25.6
8.3
11
5
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
7.4
7
*
DDD20
NOMESCO Finland
Interposition between eardrum and footplate of stapes
+∞
7.4
7
*
YPA00
NOMESCO Finland
Excision of blood vessel for transplantation
+∞
7.4
7
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
4.5
6.9
21
61
Z97.4
ICD-10 Finland
Presence of external hearing-aid
10.0
6.4
12
14
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
6.3
6
*
DCA30
NOMESCO Finland
Exploration of middle ear
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
13
213
0.52
1.27
2.5
2.5
—
—
—
0
0
5
20
2.61
1.17
1.4
1.5
—
249.09
—
0
11
12
195
0.54
1.13
2.8
2.1
130.92
148.02
u/l
0.14
12
186
13
202
0.56
1.04
2.1
3.5
0.00
0.00
estimate
—
5
63
6
28
2.25
0.94
2.3
2.8
—
—
—
0
0
20
271
0.64
0.90
3.0
3.8
0.00
0.00
estimate
—
5
65
59
528
1.69
0.86
20.4
20.3
333.93
331.42
g/l
1.60
59
528
6
107
0.52
0.80
2.7
2.7
13.70
13.03
umol/l
—
6
97
0
27
0.00
0.79
0.0
1.2
—
0.52
—
0
7
9
58
1.63
0.73
1.3
1.4
—
—
—
0
0
5
91
0.52
0.73
20.2
7.4
103.40
103.97
mmol/l
—
5
91
15
208
0.65
0.72
3.7
3.6
0.00
0.00
estimate
—
5
70
20
254
0.70
0.60
3.4
3.5
20.91
32.93
ng/l
0.49
11
177
30
356
0.73
0.60
3.1
3.9
0.00
0.00
estimate
—
5
77
6
35
1.78
0.59
3.0
2.2
176.00
297.72
ng/l
—
6
30
0
23
0.00
0.59
0.0
2.2
—
3.45
—
0
15
6
36
1.73
0.58
5.8
5.6
—
—
—
0
0
30
355
0.73
0.58
3.2
3.9
0.00
0.00
estimate
—
5
79
6
96
0.59
0.57
2.2
2.7
23.17
22.11
%
—
6
89
22
272
0.72
0.56
2.2
2.0
—
—
—
0
0
22
175
1.37
0.52
1.4
1.6
—
—
—
0
0
7
100
0.67
0.43
1.1
1.3
—
—
—
0
0
7
105
0.63
0.43
2.1
2.6
2.36
2.37
g/l
—
7
90
5
33
1.55
0.42
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
5.0
—
30.10
—
0
10
0
16
0.00
0.41
0.0
1.6
—
91.20
—
0
16
0
17
0.00
0.41
0.0
1.6
—
60.76
—
0
17
0
17
0.00
0.41
0.0
3.5
—
2.36
—
0
11
0
17
0.00
0.41
0.0
5.5
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
7.96
—
0
18
19
230
0.76
0.40
3.2
4.0
9.64
11.50
mg/mmol
0.10
13
146
0
19
0.00
0.39
0.0
2.0
—
24.31
—
0
19
33
290
1.26
0.37
2.6
3.0
—
—
estimate
—
0
0
12
154
0.73
0.37
1.3
1.3
1.87
2.41
g/l
—
7
89
11
83
1.38
0.34
2.9
6.7
1.21
1.04
mmol/l
0.83
11
77
6
46
1.33
0.34
1.2
1.4
—
—
—
0
0
19
225
0.79
0.33
2.8
3.6
—
—
—
0
0
10
76
1.37
0.30
1.7
1.5
—
—
—
0
0
33
365
0.82
0.30
3.2
3.9
0.00
0.00
estimate
—
5
77
8
64
1.28
0.29
1.4
1.7
—
—
—
0
0
19
220
0.81
0.26
2.7
3.5
39.36
66.03
mg/l
0.50
14
148
34
371
0.84
0.25
6.1
4.9
6.70
6.66
mmol/l
0.03
29
343
40
429
0.85
0.23
4.2
4.4
—
66.83
—
0
6
14
165
0.81
0.22
5.4
4.9
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
65.45
—
0
11
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
19
216
0.84
0.21
3.5
6.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
31.58
—
0
12
0
12
0.00
0.21
0.0
3.8
—
106.83
—
0
12
0
12
0.00
0.21
0.0
3.8
—
1.19
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
3.8
—
4.03
—
0
12
0
13
0.00
0.21
0.0
2.5
—
10.08
—
0
13
0
13
0.00
0.21
0.0
2.8
—
4.92
—
0
13
0
13
0.00
0.21
0.0
2.8
—
8.48
—
0
13
0
13
0.00
0.21
0.0
1.6
—
4.88
—
0
13
0
14
0.00
0.20
0.0
2.3
—
15.76
—
0
14
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
14
162
0.83
0.18
2.0
5.4
—
—
—
0
0
7
60
1.18
0.18
2.3
1.3
—
—
—
0
0
9
81
1.13
0.16
1.3
1.5
—
—
—
0
0
32
298
1.13
0.15
2.7
3.2
106.67
114.96
ug/l
0.09
32
272
15
132
1.17
0.14
3.3
3.6
334.50
241.29
ng/l
—
10
96
15
169
0.86
0.14
1.7
2.1
1.94
2.98
mg/l
1.30
15
148
9
107
0.82
0.14
1.7
1.5
—
—
—
0
0
23
249
0.89
0.13
1.8
3.2
—
—
—
0
0
12
134
0.87
0.09
1.3
1.7
411.17
509.99
pmol/l
0.75
12
108
65
657
0.87
0.09
15.1
13.9
—
—
—
0
0
6
54
1.12
0.09
1.3
1.9
—
—
—
0
0
6
73
0.81
0.08
1.0
1.2
—
—
—
0
0
12
108
1.13
0.08
2.3
3.4
0.84
0.81
mmol/l
0.30
12
101
9
83
1.10
0.07
1.2
1.5
—
—
—
0
0
24
227
1.09
0.07
5.0
4.9
—
—
—
0
0
42
433
0.93
0.06
4.1
4.5
—
—
—
0
0
27
283
0.93
0.06
1.5
2.0
91.33
102.97
pmol/l
—
10
131
16
151
1.08
0.03
3.2
3.9
1.02
1.02
kg/l
—
7
94
12
127
0.93
0.02
1.7
1.8
—
—
—
0
0
17
176
0.96
0.00
2.2
2.9
344.76
336.55
umol/l
0.13
17
149
21
204
1.04
0.00
3.5
3.3
—
—
—
0
0
13
129
1.01
0.00
1.2
1.4
1.26
12.23
u/ml
—
7
57
31
314
0.98
0.00
6.9
7.9
1.19
1.21
mmol/l
0.74
26
274
5
59
0.84
-0.00
6.6
1.6
8.06
10.58
g/l
—
5
54
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
9.44
—
0
5
0
5
0.00
-0.00
0.0
9.8
—
0.61
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
25.80
—
0
5
0
9
0.00
-0.00
0.0
1.7
—
89.47
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
-2.10
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
64
637
1.05
-0.00
14.8
15.6
27.33
21.93
mg/l
0.62
53
509
6
59
1.02
-0.00
4.8
3.0
0.20
0.22
g/l
—
6
54
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
6
62
0.96
-0.00
1.5
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
16.14
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
98
0.91
-0.00
2.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
6.06
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
205.97
—
0
7
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
121.80
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
2.83
—
0
6
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
75.50
—
0
5
0
9
0.00
-0.00
0.0
1.2
—
34.06
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
45.40
—
0
5
0
8
0.00
-0.00
0.0
4.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.3
—
70.57
—
0
7
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H8_OSSICABN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have H8_OSSICABN.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: H8_OSSICABN – Abnormalities of ear ossicles

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data